• Home
  • About ADW Law
  • Our Team
  • Areas of Practice
    • Pharmaceuticals and Medical Devices
    • Securities Investment Fraud
  • Blog and News
    • Justice Blog
    • Pharmaceuticals and Medical Devices
    • Investment Securities
  • Contact ADW
Dan Woska's LinkedIn
Home » Pharmaceuticals and Medical Devices » Asbestos Exposure and Malignment Mesothelioma

Asbestos Exposure and Malignant Mesothelioma

Malignant mesothelioma is an uncommon form of cancer, and the most serious of all asbestos related diseases. Malignant mesothelioma is caused almost exclusively by the inhalation of airborne asbestos particles. It is a “signature disease” of asbestos exposure because in the absence of asbestos exposure, mesothelioma is almost nonexistent. Malignant mesothelioma can develop up to 40 years after the initial asbestos exposure. The incidence of mesothelioma rises with the intensity and duration of asbestos exposure. Cases of mesothelioma among people with very little asbestos exposure have been documented. Many of those who are being diagnosed with mesothelioma today unknowingly experienced asbestos exposure many years ago.

The symptoms associated with the disease make it difficult for doctors to diagnose. Often, by the time that a proper diagnosis is made, the disease has progressed to a point where patients do not respond well to treatment therapy. Another unique factor associated with the disease is that there can be a long latency period, twenty to forty years, between the time an individual is exposed to asbestos and the actual manifestation of the disease in the form of malignant mesothelioma. Depending on the kind of tissue and organ involved in the cancer, there are several forms of this disease.

About the author

admin
admin

Related Posts

  • Exposed Populations
    Exposed PopulationsMay 25, 2011
  • Asbestos
    AsbestosMay 25, 2011
  • Asbestos and Mesothelioma an Overview
    Asbestos and Mesothelioma an OverviewSeptember 1, 2008

Popular Posts

  • Creosote Blues Revisited
    Creosote Blues RevisitedApril 18, 2008
  • Glaxo First-Quarter Profits Falls on Avandia, Generics
    Glaxo First-Quarter Profits Falls on Avandia, GenericsApril 23, 2008
  • Diabetes drugs doubles fracture risk
    Diabetes drugs doubles fracture riskApril 28, 2008

Leave a Reply

Click here to cancel reply.

Post Comment

Blog and News Navigation

  • Justice Blog
  • Pharmaceuticals and Medical Devices
  • Investment Securities

Our Services

  • Pharmaceuticals and Medical Devices
  • Securities Investment Fraud

Popular Blog and News Topics

Aranesp Asbestos Avamere Avandia Bayer birth control diabetes drugs GlaxoSmithKline Greedy GSK Illegal Mesothelioma Yasmin

Contact Us

Your message was successfully sent. Thank You!

DISCLAIMER-PLEASE STOP AND READ CAREFULLY

This Website is intended for informational purposes only. The content contained in this Website is not legal advice and should not be relied on as such. Legal advice cannot be given without full consideration of all relevant information relating to your specific situation. No attorney-client relationship is created by viewing, downloading or making any other use of this Website. The law firm of A. Daniel Woska & Associates, P.C. will represent clients only upon execution of a signed retainer agreement.

Popular Topics

Aranesp Asbestos Avamere Avandia Bayer birth control diabetes drugs GlaxoSmithKline Greedy GSK Illegal Mesothelioma Yasmin

Featured Attorney

  • Tara T. Tabatabaie
    Tara T. Tabatabaie
    Tara Tabatabaie received her J.D. from Oklahoma City University School of Law in 2007, graduating Magna Cum Laude. In addition to her legal expertise, Tara holds a Ph.D. in chemistry. She was a Research Scientist at the Oklahoma Medical Research Foundation in Oklahoma City for over 10 years before becoming a lawyer. Her scientific work ...
    See Full Information »

Website Search

Contact ADW

(405) 562-1046

inquiry@woskalawfirm.com

Your message was successfully sent. Thank You!

Copyright © 2011 A. Daniel Woska & Associates, P.C. All Rights Reserved. Developed by YBR Design
Terms & Privacy